230 related articles for article (PubMed ID: 18824449)
1. New targeted therapies and small-cell lung cancer.
Rossi A; Maione P; Palazzolo G; Sacco PC; Ferrara ML; Falanga M; Gridelli C
Clin Lung Cancer; 2008 Sep; 9(5):271-9. PubMed ID: 18824449
[TBL] [Abstract][Full Text] [Related]
2. The role of new targeted therapies in small-cell lung cancer.
Rossi A; Maione P; Colantuoni G; Guerriero C; Gridelli C
Crit Rev Oncol Hematol; 2004 Jul; 51(1):45-53. PubMed ID: 15207253
[TBL] [Abstract][Full Text] [Related]
3. Extensive-stage small-cell lung cancer: evolution of systemic therapy and future directions.
Allen J; Jahanzeb M
Clin Lung Cancer; 2008 Sep; 9(5):262-70. PubMed ID: 18953759
[TBL] [Abstract][Full Text] [Related]
4. Treatment of small cell lung cancer in the elderly.
Rossi A; Maione P; Colantuoni G; Guerriero C; Ferrara C; Del Gaizo F; Nicolella D; Gridelli C
Oncologist; 2005; 10(6):399-411. PubMed ID: 15967834
[TBL] [Abstract][Full Text] [Related]
5. Update on new drugs in small cell lung cancer.
Horn L; Castellanos EL; Johnson DH
Expert Opin Investig Drugs; 2011 Apr; 20(4):441-5. PubMed ID: 21395484
[TBL] [Abstract][Full Text] [Related]
6. Treatment of non-small-cell lung cancer: state of the art and development of new biologic agents.
Gridelli C; Rossi A; Maione P
Oncogene; 2003 Sep; 22(42):6629-38. PubMed ID: 14528288
[TBL] [Abstract][Full Text] [Related]
7. Emerging drugs for small-cell lung cancer.
Metro G; Cappuzzo F
Expert Opin Emerg Drugs; 2009 Dec; 14(4):591-606. PubMed ID: 19694501
[TBL] [Abstract][Full Text] [Related]
8. Medical treatment of small cell lung cancer: state of the art and new development.
Sgambato A; Casaluce F; Maione P; Rossi A; Sacco PC; Panzone F; Ciardiello F; Gridelli C
Expert Opin Pharmacother; 2013 Oct; 14(15):2019-31. PubMed ID: 23901936
[TBL] [Abstract][Full Text] [Related]
9. The role of targeted therapy in non-small cell lung cancer.
Maione P; Rossi A; Airoma G; Ferrara C; Castaldo V; Gridelli C
Crit Rev Oncol Hematol; 2004 Jul; 51(1):29-44. PubMed ID: 15207252
[TBL] [Abstract][Full Text] [Related]
10. Alternatives to chemotherapy and radiotherapy in the treatment of small cell lung cancer.
Shepherd FA
Semin Oncol; 2001 Apr; 28(2 Suppl 4):30-7. PubMed ID: 11479895
[TBL] [Abstract][Full Text] [Related]
11. Treatment of extensive-stage small cell lung carcinoma: current status and future prospects.
Demedts IK; Vermaelen KY; van Meerbeeck JP
Eur Respir J; 2010 Jan; 35(1):202-15. PubMed ID: 20044461
[TBL] [Abstract][Full Text] [Related]
12. [Drug therapy for small-cell lung cancer (SCLC)--new molecular strategies for therapy].
Brückl WM; Lampert S; Zirlik S; Hahn EG; Wiest GH
Pneumologie; 2008 Jan; 62(1):23-30. PubMed ID: 17948174
[TBL] [Abstract][Full Text] [Related]
13. New advances in the second-line treatment of small cell lung cancer.
Hurwitz JL; McCoy F; Scullin P; Fennell DA
Oncologist; 2009 Oct; 14(10):986-94. PubMed ID: 19819917
[TBL] [Abstract][Full Text] [Related]
14. Ganitumab for the treatment of small-cell lung cancer.
Martínez P; Sales Fidalgo PA; Felip E
Expert Opin Investig Drugs; 2014 Oct; 23(10):1423-32. PubMed ID: 25189625
[TBL] [Abstract][Full Text] [Related]
15. Analysis of lung cancer patients enrolled in CTEP (cancer therapy evaluation program)-sponsored phase I trials.
Gadgeel SM; Ivy P; Chen W; Mauer J; Smith D; Lorusso P
Clin Lung Cancer; 2011 Jul; 12(4):218-23. PubMed ID: 21726820
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in management of small-cell lung cancer.
Chua YJ; Steer C; Yip D
Cancer Treat Rev; 2004 Oct; 30(6):521-43. PubMed ID: 15325033
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome of amrubicin therapy according to the prior chemotherapy sensitivities of extensive small cell lung cancer.
Mitsuoka S; Kudoh S; Kimura T; Yoshimura N; Tanaka H; Suzumura T; Umekawa K; Nagata M; Ueda T; Hirata K
Osaka City Med J; 2011 Dec; 57(2):59-66. PubMed ID: 22443079
[TBL] [Abstract][Full Text] [Related]
18. Targeted therapies for small cell lung cancer: Where do we stand?
Arcaro A
Crit Rev Oncol Hematol; 2015 Aug; 95(2):154-64. PubMed ID: 25800975
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of novel treatment strategies.
Giaccone G
Oncogene; 2002 Oct; 21(45):6970-81. PubMed ID: 12362278
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancer.
Kaira K; Sunaga N; Tomizawa Y; Yanagitani N; Shimizu K; Imai H; Utsugi M; Iwasaki Y; Iijima H; Tsurumaki H; Yoshii A; Fueki N; Hisada T; Ishizuka T; Saito R; Mori M
Lung Cancer; 2010 Jul; 69(1):99-104. PubMed ID: 19853960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]